DSS, Inc. Names Jason Grady as Interim Chief Executive Officer
August 26, 2024 16:08 ET
|
DSS, Inc.
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) has announced the appointment of Jason Grady as its Interim CEO, effective August 23, 2024. Grady, who previously served as...
Impact Biomedical Inc. Files Current Report on Form 8-K
November 15, 2023 13:57 ET
|
Impact BioMedical, Inc.
NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc. (“the Company” and “Impact”) announced today that the Company filed a Current Report on Form 8-K with the Securities and Exchange...